Hot Keywords
Biomarker Discovery Autophagy and Cancer Breast Cancer Metastasis Brain Metastases Gastric Cancer Metastasis Lung Cancer Genetic Heterogeneity Colorectal Cancer Prostate Cancer Cancer Immunotherapy Circulating Tumor Cells Neuroendocrine Tumors

The paper's citation list
No.The paper's citation list
1Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion. 2021;10:582 doi: 10.3390/jcm10040582
2Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer. 2021;13:4808 doi: 10.3390/cancers13194808
3Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors. 2021;18:1455 doi: 10.1021/acs.molpharmaceut.1c00018
4Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance. 2020;22: doi: 10.1186/s13058-020-01325-3
5The role of interactomic interactions in tamoxifen-resistant breast cancer: new approaches to searching for the mechanisms of pathogenesis. 2020;9:80 doi: 10.17116/onkolog2020906180
6An Interdependence between Estrogen Receptor 1 Gene Polymorphisms and Susceptibility to Breast Cancer. 2021;1: doi: 10.5812/tms.117221
7Widespread Exaptation of L1 Transposons for Transcription Factor Binding in Breast Cancer. 2021;22:5625 doi: 10.3390/ijms22115625
8Understanding the interaction of estrogenic ligands with estrogen receptors: a survey of the functional and binding kinetic studies. 2020;38:142 doi: 10.1080/26896583.2020.1761204
9Opportunities for Antigen Discovery in Metastatic Breast Cancer. 2020;11: doi: 10.3389/fimmu.2020.570049
10Identification and targeting of selective vulnerability rendered by tamoxifen resistance. 2020;22: doi: 10.1186/s13058-020-01315-5
11Management of hormone receptor–positive, human epidermal growth factor 2–negative metastatic breast cancer. 2021;190:189 doi: 10.1007/s10549-021-06383-5
12microRNA-Dependent Modulation of Genes Contributes to ESR1's Effect on ERα Positive Breast Cancer. 2020;10: doi: 10.3389/fonc.2020.00753
13Integrated transcription factor profiling with transcriptome analysis identifies L1PA2 transposons as global regulatory modulators in a breast cancer model. 2021;11: doi: 10.1038/s41598-021-86395-9
14Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis. 2021;10:2966 doi: 10.3390/cells10112966
15PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α–Positive Breast Cancer Cells. 2021;19:1688 doi: 10.1158/1541-7786.MCR-21-0103
16Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer. 2020;21:8807 doi: 10.3390/ijms21228807
17Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer. 2020;21:4068 doi: 10.3390/ijms21114068
18Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis. 2021;11: doi: 10.3389/fonc.2021.645698
19Genomic Assays in Node Positive Breast Cancer Patients: A Review. 2021;10: doi: 10.3389/fonc.2020.609100
20Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations. 2020;10:698 doi: 10.3390/biom10050698
21Circulating Tumor Cells in Metastatic Breast Cancer: From Genome Instability to Metastasis. 2020;7: doi: 10.3389/fmolb.2020.00134
22Identification of Key lncRNA–mRNA Pairs and Functional lncRNAs in Breast Cancer by Integrative Analysis of TCGA Data. 2021;12: doi: 10.3389/fgene.2021.709514
23Detection of ESR1 Mutations Based on Liquid Biopsy in Estrogen Receptor-Positive Metastatic Breast Cancer: Clinical Impacts and Prospects. 2020;10: doi: 10.3389/fonc.2020.587671
24Identification of molecular biomarkers and pathways of NSCLC: insights from a systems biomedicine perspective. 2021;19: doi: 10.1186/s43141-021-00134-1
25FOXO transcription factor family in cancer and metastasis. 2020;39:681 doi: 10.1007/s10555-020-09883-w
26Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis. 2021;12: doi: 10.1007/s12672-021-00432-7
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties